Literature DB >> 11296072

Partial uptake of varicella vaccine and the epidemiological effect on varicella disease in 11 day-care centers in North Carolina.

D A Clements1, J I Zaref, C L Bland, E B Walter, P M Coplan.   

Abstract

BACKGROUND: The increasing use of varicella vaccine in children attending day care has rapidly decreased the incidence of wild-type varicella disease. The herd immunity noted is significant and will have an effect on the epidemiology of natural varicella.
OBJECTIVE: To monitor the change in varicella incidence in day-care attendees after the licensure of varicella vaccine.
DESIGN: A prospective observational cohort study design.
SETTING: Eleven private day-care centers and preschools in North Carolina participated in the study from January 1, 1995, through December 31, 1999. PARTICIPANTS: All children in the 11 centers were eligible for participation. Some participated more actively, supplying information on a regular basis. Others participated passively. Day-care personnel provided information about all cases of varicella.
INTERVENTIONS: None. MAIN OUTCOME VARIABLES: The change in the incidence of varicella disease was documented as the use of varicella vaccine increased.
RESULTS: Varicella vaccine coverage increased substantially from 4.4% in 1995 to 63.1% in December 1999. The vaccination rate accelerated dramatically in 1996 and 1997, leveled off in 1998, and rose again in 1999. Cumulative varicella incidence decreased from 16.74 cases per 1000 person-months in July 1996 to 1.53 cases per 1000 person-months in December 1999 in unvaccinated children.
CONCLUSIONS: The varicella vaccination rate continued to increase slowly in the day-care population after an initial rapid uptake. The decrease in varicella disease is greater than the increase in varicella vaccination. This herd effect is welcome and even apparent in the unvaccinated children younger than 1 year.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11296072     DOI: 10.1001/archpedi.155.4.455

Source DB:  PubMed          Journal:  Arch Pediatr Adolesc Med        ISSN: 1072-4710


  9 in total

1.  Digital epidemiology reveals global childhood disease seasonality and the effects of immunization.

Authors:  Kevin M Bakker; Micaela Elvira Martinez-Bakker; Barbara Helm; Tyler J Stevenson
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-31       Impact factor: 11.205

Review 2.  Preventing varicella-zoster disease.

Authors:  Sophie Hambleton; Anne A Gershon
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

3.  Seroprevalence of antibodies against measles, rubella, mumps, varicella-zoster, and B. Pertussis in young adults of Madrid, Spain.

Authors:  Alba González-Escalada; Laura García-García; Pablo Viguera-Ester; Patricia Marín-García; Jesus García; Angel Gil-de-Miguel; Ruth Gil-Prieto
Journal:  Hum Vaccin Immunother       Date:  2013-06-21       Impact factor: 3.452

Review 4.  Active immunization in the United States: developments over the past decade.

Authors:  P H Dennehy
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

5.  Severe complications of chickenpox in hospitalised children in the UK and Ireland.

Authors:  J C Cameron; G Allan; F Johnston; A Finn; P T Heath; R Booy
Journal:  Arch Dis Child       Date:  2007-11-08       Impact factor: 3.791

6.  A double blind, randomized, active controlled study to assess the safety, tolerability and immunogenicity of measles, mumps rubella, and varicella vaccine (MMRV) manufactured using an alternative process.

Authors:  Gary S Marshall; Shelly D Senders; Julie Shepard; Jerry D Twiggs; Julie Gardner; Darcy Hille; Jonathan Hartzel; Rowan Valenzuela; Jon E Stek; Frans A Helmond
Journal:  Hum Vaccin Immunother       Date:  2016-05-05       Impact factor: 3.452

7.  Evaluating human papillomavirus vaccination programs.

Authors:  Al V Taira; Christopher P Neukermans; Gillian D Sanders
Journal:  Emerg Infect Dis       Date:  2004-11       Impact factor: 6.883

8.  The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003.

Authors:  W Katherine Yih; Daniel R Brooks; Susan M Lett; Aisha O Jumaan; Zi Zhang; Karen M Clements; Jane F Seward
Journal:  BMC Public Health       Date:  2005-06-16       Impact factor: 3.295

9.  Burden of varicella complications in secondary care, England, 2004 to 2017.

Authors:  James Lopez Bernal; Peter Hobbelen; Gayatri Amirthalingam
Journal:  Euro Surveill       Date:  2019-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.